Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Intracardiac Echocardiography Market/ICE Market Size, Share & Trends by Product, Application (Valve Defects, Electrophysiology, Monitoring), End user (Hospital, ASC, Diagnostic Centers) & Region Global Forecasts to 2029" report has been added to ResearchAndMarkets.com's offering.
The global intracardiac echocardiography (ICE) market is projected to reach USD 545 million by 2029 from USD 333 million in 2024, growing at a CAGR of 10.3%
Prominent players in this market are Johnson & Johson Medtech (US), Medtronic (Ireland), Abbott Laboratories (US), Siemens Healthineers (Germany), Philips healthcare (Netherland) among others.
The projected market growth for intracardiac echocardiography (ICE) is supported by the convergence of benefits. The projected expansion of the intracardiac echocardiography (ICE) market is driven by demographic trends favoring an aging population, continuous advancements in diagnostic technologies, increased adoption of advanced imaging tools, and the capability to deliver real-time, high-resolution imaging of cardiac structures and blood flow. These factors synergistically contribute to the growth prospects of the ICE market in the forecasted period.
ICE Ultrasound Systems with Inbuild Software Applications segment to register largest market share in 2023-2029.
Based on the product, the intracardiac echocardiography (ICE) market is segmented into ICE Ultrasound Systems with Inbuild Software Applications (2D ultrasound systems, 3D/4D ultrasound systems, doppler ultrasound systems), ICE Catheters (Dopper ICE catheters, phased - array ICE catheters, fixed - array ICE catheters, mechanical rotational ICE catheters), ICE Consoles (cart/ trolley-based consoles, hand-held/ portable consoles), guiding catheters and sheaths, disposable accessories, and softwares are used in intracardiac echocardiography (ICE) taken into account while estimating the entire market.
The ICE Ultrasound Systems segment registered the largest market share for the forecasted year of 2024-2029. Developments in ultrasound transducer technology and catheter designs, as well as its integration with other imaging tools to give comprehensive visualisation and navigation, are responsible for the emergence of intracardiac echocardiography ultrasound systems. Consumer demand for minimally invasive procedures, improved software applications, and an increase in the rate of coronary diseases are all contributing to the expansion and widespread use of ICE ultrasound devices.
Electrophysiolgy segment held the largest share of intracardiac echocardiography (ICE) market in 2023, by application.
Based on the application, the intracardiac echocardiography (ICE) market is segmented into electrophysiology, structural heart defects (mitral valve repair/ replacement, aortic valve replacement and other heart defects), cardiac monitoring, left atrial appendage closure, and other applications. In 2023, the electrophysiolgy segment accounted the largest share of global intracardiac echocardiography (ICE) market.
Real-time visualization capabilities, improved safety and accuracy in procedures, and the ability to monitor cardiac health over extended periods for early disease detection are pivotal drivers propelling growth in the electrophysiology in intracardia echocardiography market.
hospitals & surgical centers: diagnostic segment held the largest share of intracardiac echocardiography (ICE) market in 2023, by End-user.
Based on the end-user, the intracardiac echocardiography (ICE) market is segmented into Hospital-based cathlabs/ hybrid or interventional, hospitals & surgical centers: diagnostic, Ambulatory surgical centers (ASCs) and independent diagnostic centers and Other end users. In 2023, the hospitals & surgical centers: diagnostic segment had the largest share of the global intracardiac echocardiography (ICE) market. T
he growth within hospital and surgical centers:diagnostic segment is propelled by continuous advancements in diagnostic technology, escalating consumer demand for superior diagnostic services, and facilitated expansion of diagnostic capabilities due to favorable regulatory environments and increased adoption of modern diagnostic tools.
Asia Pacific to register significant growth rate in the market during the forecast period.
For the forecasting period 2024-2029, The Asia-Pacific (APAC) region is anticipated to experience substantial growth throughout the forecast period. Asia Pacific comprises Japan, India, China, South Korea, Australia, and RoAPAC. The Asia-Pacific (APAC) region has experienced a notable acceleration in the market growth rate for intracardiac echocardiography (ICE).
Several factors have contributed to the growth of the intracardiac echocardiography (ICE) market in the APAC region. Continuous innovations in ultrasound technology are driving this expansion. Additionally, governments in the Asia Pacific are making significant investments in healthcare infrastructure and advanced medical technologies. The rising incidence of cardiovascular diseases in the region further increases the demand for advanced diagnostic and imaging technologies like ICE, aiming to enhance patient care and outcomes.
The report provides insights on the following pointers:
- Analysis of key drivers (increasing cardiac issues in overall population, collaboration of other imaging techniques and AI with intracardiac echocardiography technology), restraints (The availability of trained personnel is inconsistent. Additionally, ICE procedures involve significant risks of complications), opportunities (scope of clinical applications for intracardiac echocardiography (ICE) in structural heart disease interventions is expanding), and challenges (incur cost barrier) influencing the growth of the intracardiac echocardiography (ICE) market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the intracardiac echocardiography (ICE) market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the intracardiac echocardiography (ICE) market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the intracardiac echocardiography (ICE) market
Key Attributes:
Report Attribute | Details |
No. of Pages | 299 |
Forecast Period | 2024 - 2029 |
Estimated Market Value (USD) in 2024 | $333 Million |
Forecasted Market Value (USD) by 2029 | $545 Million |
Compound Annual Growth Rate | 10.3% |
Regions Covered | Global |
Companies Featured
- Medtronic
- Abbott and Approvals
- Siemens Healthineers AG and Approvals
- GE Healthcare
- Boston Scientific Corporation
- Philips Healthcare and Approvals
- Johnson & Johnson Medtech and Approvals
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Edwards Lifesciences Corporation
- Canon Medical Systems Corporation
- Fujifilm Holdings Corporation
- Guerbet
- Terumo Corporation
- Livanova
- Infraredx Inc.
- Stereotaxis, Inc.
- B. Braun SE
- Esaote Spa
- Chison Medical Technologies Co. Ltd.
- Shifamed, LLC
- Conavi Medical Inc.
- Xuzhou Kaixin Electronic Instrument Co. Ltd.
- Bk Medical
- Benq Medical Technology
- Echonous Inc.
- Volta Medical
- Trivitron Healthcare
- Echopixel
- Cathvision
- Pie Medical Imaging Bv
For more information about this report visit https://www.researchandmarkets.com/r/i65ljc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment